Ignoring SARS-CoV-2 testing performance during COVID-19

Buchta C., Zeichhardt H., Griesmacher A., Schellenberg I., Kammel M.

Publication type: Journal Article

Publication date: 2023-05-01

Elsevier

Journal: The Lancet Microbe

scimago Q1

SJR: 5.392

CiteScore: 27.2

Impact factor: 20.9

ISSN: 26665247

DOI: 10.1016/s2666-5247(23)00030-7

Copy DOI

Microbiology (medical)

Microbiology

Infectious Diseases

Virology

Abstract

The Lancet Commission on lessons for the future from the COVID-19 pandemic1 discusses a series of failures during this challenging time, and we acknowledge the authors' comprehensive and important work. However, the authors refrained from discussing the urgent need to closely monitor the performance of SARS-CoV-2 testing, and to act when underperforming testing facilities and test systems were identified.

Found

	1 2
The Lancet Microbe	The Lancet Microbe, 2, 50% The Lancet Microbe 2 publications, 50%
Wiener Klinische Wochenschrift	Wiener Klinische Wochenschrift, 1, 25% Wiener Klinische Wochenschrift 1 publication, 25%
Clinical Chemistry and Laboratory Medicine	Clinical Chemistry and Laboratory Medicine, 1, 25% Clinical Chemistry and Laboratory Medicine 1 publication, 25%
	1 2

	1 2
Elsevier	Elsevier, 2, 50% Elsevier 2 publications, 50%
Springer Nature	Springer Nature, 1, 25% Springer Nature 1 publication, 25%
Walter de Gruyter	Walter de Gruyter, 1, 25% Walter de Gruyter 1 publication, 25%
	1 2

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex | MLA

Found error?

Publisher

Elsevier

Journal

The Lancet Microbe

scimago Q1

SJR

5.392

CiteScore

27.2

Impact factor

20.9

ISSN

26665247 (Print)

Profiles

Buchta, Christoph

Ignoring SARS-CoV-2 testing performance during COVID-19

Top-30

Journals

Publishers

Are you a researcher?